Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Accord healthcare

02 23Amgen Inc

03 2Biosimilar Collaborations Ireland Limited

04 4Celltrion

05 2Fresenius Kabi USA

06 2Gedeon Richter

07 2Mabxience

08 8Samsung Bioepis

09 13Sandoz B2B

10 1Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Jubereq

Dosage Form : Injectable Solution

Dosage Strength : 120mg

Packaging :

Approval Date : 26/05/2025

Application Number : 20240307000028

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB

Brand Name : PROLIA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB

Brand Name : XGEVA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Xgeva

Dosage Form : Solution for injection, solution in pre-filled syringe

Dosage Strength : 120 mg

Packaging : Pre-filled syringe 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BMWO

Brand Name : STOBOCLO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761404

Regulatory Info :

Registration Country : USA

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BMWO

Brand Name : OSENVELT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG/1.7ML(70MG/ML)

Packaging :

Approval Date :

Application Number : 761404

Regulatory Info :

Registration Country : USA

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BNHT

Brand Name : BOMYNTRA

Dosage Form : INJECTION

Dosage Strength : 120MG/1.7ML (70 MG/ML)

Packaging :

Approval Date :

Application Number : 761398

Regulatory Info :

Registration Country : USA

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BNHT

Brand Name : CONEXXENCE

Dosage Form : INJECTION

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761398

Regulatory Info :

Registration Country : USA

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Junod

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 23/06/2025

Application Number : 20240701000372

Regulatory Info : Approved

Registration Country : Sweden

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Denbrayce

Dosage Form : Injectable Solution

Dosage Strength : 120mg

Packaging :

Approval Date : 26/06/2025

Application Number : 20240424000048

Regulatory Info : Approved

Registration Country : Sweden

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Izamby

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 26/06/2025

Application Number : 20240424000024

Regulatory Info : Approved

Registration Country : Sweden

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-DSSB

Brand Name : OSPOMYV

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-DSSB

Brand Name : XBRYK

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-DSSB

Brand Name : DENOSUMAB-DSSB

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-DSSB

Brand Name : DENOSUMAB-DSSB

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Obodence

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 12/02/2025

Application Number : 20240308000126

Regulatory Info : Approved

Registration Country : Sweden

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BBDZ

Brand Name : JUBBONTI

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761362

Regulatory Info :

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DENOSUMAB-BBDZ

Brand Name : WYOST

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 120MG/1.7ML (70MG/ML)

Packaging :

Approval Date :

Application Number : 761362

Regulatory Info :

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Jubbonti

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 16/05/2024

Application Number : 20230426000016

Regulatory Info : Approved

Registration Country : Sweden

blank

20

Biosimilar Collaborations Ireland L...

Country
The MedTech Conference
Not Confirmed
arrow

Biosimilar Collaborations Ireland L...

Country
arrow
The MedTech Conference
Not Confirmed

Denosumab

Brand Name : Evfraxy

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 30/06/2025

Application Number : 20240802000295

Regulatory Info : Approved

Registration Country : Sweden

blank